Equities

Mirion Technologies Inc

Mirion Technologies Inc

Actions
IndustrialsElectronic and Electrical Equipment
  • Price (USD)9.98
  • Today's Change0.04 / 0.40%
  • Shares traded694.00
  • 1 Year change+18.53%
  • Beta0.8041
Data delayed at least 15 minutes, as of May 04 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Medical and Technologies. The Medical segment includes products and services for radiation therapy and personal dosimetry. This segment's offerings include solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy; solutions for monitoring the total amount of radiation medical staff members are exposed to over time, and products for nuclear medicine in radiation measurement, shielding, product handling, medical imaging furniture and rehabilitation. The Technologies segment includes products and services for defense, nuclear energy, laboratories and research and other industrial markets. This segment's offerings include reactor safety and control systems, and radiological search, measurement and analysis systems.

  • Revenue in USD (TTM)811.40m
  • Net income in USD-80.80m
  • Incorporated2018
  • Employees3.00k
  • Location
    Mirion Technologies Inc1218 Menlo DriveATLANTA 30318United StatesUSA
  • Phone+1 (770) 432-2744
  • Fax+1 (302) 636-5454
  • Websitehttps://www.mirion.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MIR:NYQ since
announced
Transaction
value
Ec2 Software Solutions LLCDeal completed01 Nov 202301 Nov 2023Deal completed44.01%--
Data delayed at least 15 minutes, as of May 04 2024 00:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Mesa Laboratories Inc212.87m948.00k623.01m698.00659.471.5517.662.930.17510.175139.5474.700.30312.385.43304,977.100.1350.65350.14380.702961.0260.100.44531.971.860.26040.3663100.9618.8517.90-50.29--10.180.00
Quanterix Corp122.37m-32.33m650.97m441.00--1.86--5.32-0.8587-0.85873.269.130.28482.645.51277,478.50-7.53-15.96-8.19-17.6657.7352.79-26.42-53.799.26--0.00--15.9626.6066.56--20.07--
Standard Biotools Inc106.34m-74.66m950.94m534.00------8.94-0.9437-0.94371.342.030.29812.665.76199,138.60-20.93-28.17-26.63-33.6047.4451.58-70.21-74.851.26-13.800.2801--8.57-1.2060.73--50.06--
CTS Corp530.18m53.31m1.52bn4.08k29.182.9218.472.871.701.7016.9117.010.71655.715.94129,913.807.204.488.345.3334.7634.7110.055.862.71--0.114617.23-6.213.191.615.56-12.350.00
Mirion Technologies Inc811.40m-80.80m2.26bn3.00k--1.5529.012.79-0.4053-0.40534.076.450.30142.943.79270,466.70-3.06---3.44--44.91---10.14--1.57-0.0880.3111--11.58--65.01------
Integra Lifesciences Holdings Corp1.54bn67.74m2.27bn3.95k34.211.4211.871.470.84440.844419.1920.310.40191.595.79390,667.301.773.331.923.6863.0963.674.397.992.187.950.48570.00-1.030.9219-62.482.19-2.97--
OSI Systems, Inc.1.47bn125.86m2.31bn6.24k18.662.8413.921.577.267.2684.9447.710.88692.333.65235,419.007.596.2312.579.1835.3235.698.567.070.88817.450.37520.008.043.25-20.4347.89-6.71--
Olink Holding AB (publ) - ADR169.60m-31.60m2.86bn707.00------16.87-0.2547-0.25471.36--0.31450.99632.94239,882.60-5.86---6.40--67.49---18.63--3.55--0.0506--21.27---145.90------
Badger Meter Inc740.77m102.31m5.56bn2.14k54.4510.3742.257.503.473.4725.1318.221.083.078.39346,154.7014.8612.2618.1714.6039.2639.3813.8112.062.30--0.0036.3624.4010.1639.2527.226.7912.07
Vontier Corp3.07bn430.90m6.10bn8.00k14.266.1910.971.982.772.7719.736.370.71635.036.21384,325.0010.0410.8012.6314.0447.1744.6214.0113.361.236.230.69352.24-2.803.03-6.08-0.50187.23--
Cognex Corp847.22m99.64m7.52bn2.99k76.185.0560.348.880.57490.57494.908.680.4251.665.72283,161.805.0010.635.5611.5670.7572.9711.7622.382.61--0.0057.03-16.750.7624-47.46-13.24-9.069.03
MKS Instruments Inc3.62bn-1.84bn8.18bn10.00k--3.30--2.26-27.56-27.5654.1736.950.35132.015.19362,100.00-17.86-1.60-19.57-1.7545.3544.95-50.84-3.252.011.160.6596--2.1111.78-652.85--6.692.44
Bio Rad Laboratories Inc2.67bn-637.32m9.41bn8.03k--0.913--3.52-21.49-21.4991.24306.510.20711.655.43332,660.30-4.949.08-5.169.6053.5655.55-23.8641.974.340.30950.12070.00-4.673.1382.43--3.83--
Data as of May 04 2024. Currency figures normalised to Mirion Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

58.33%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202320.86m9.54%
T. Rowe Price Investment Management, Inc.as of 31 Dec 202319.87m9.09%
Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 202318.78m8.59%
Goldman Sachs Asset Management LPas of 31 Dec 202316.03m7.33%
BlackRock Fund Advisorsas of 31 Dec 202313.55m6.20%
Swedbank Robur Fonder ABas of 29 Feb 202410.64m4.86%
Janus Henderson Investors US LLCas of 31 Dec 20239.31m4.26%
Omega Advisors, Inc.as of 31 Dec 20237.51m3.44%
P2 Capital Partners LLCas of 31 Dec 20235.85m2.67%
Alyeska Investment Group LPas of 31 Dec 20235.16m2.36%
More ▼
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.